Loading company…
Saint Medical develops heart valve systems and technologies for structural heart disease.
Founded in 2019 and based in Nanjing, China, Saint Medical develops heart valve systems for cardiovascular patients, including aortic and mitral valve replacement products. It also provides platforms for structural heart disease diagnosis and treatment technology. The company plans to use Series A2 funding to support clinical trials and develop structural heart treatments and related digital services.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in